A Novel Liquid Chromatography‐Tandem Mass Spectrometry Method for Estimation of Solriamfetol: An Application to Spiked Human Plasma

A Novel Liquid Chromatography‐Tandem Mass Spectrometry Method for Estimation of Solriamfetol: An Application to Spiked Human Plasma Naga Prashant K Sri Adichunchanagiri College of Pharmacy Adichunchanagiri University B.G. Nagara India Vijaya Lakshmi A Department of Pharmacognosy School of Pharmaceutical Sciences Vels Institute of Science, Technology and Advanced Studies Chennai India Suvarna Yenduri Sri Adichunchanagiri College of Pharmacy Adichunchanagiri University B.G. Nagara India ABSTRACT

Solriamfetol, an emerging drug for the treatment of excessive daytime sleepiness along with narcolepsy and obstructive sleep apnoea. It acts as a dopamine and norepinephrine reuptake inhibitor. The present study aimed to develop a liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method for the estimation of Solriamfetol in spiked human plasma, using 13‐C Solriamfetol as an internal standard (IS). All the chromatographic conditions were optimized to obtain a sharp, symmetrical peak of Solriamfetol in a chromatographic run. The chromatographic conditions include 0.1% formic acid and acetonitrile (30:70) as the mobile phase, a C18 column as the stationary phase. Multiple reaction monitoring mode was selected for ionization and fragmentation, and the maximum sensitivity was achieved in the mass spectrometer. The results of validation parameters showed the developed method as precise, accurate, and robust. The linearity concentration is in the range of 5.0–5220.0 ng/mL with a correlation coefficient of 0.9980. All the stability showed the method's reliability under various conditions. The developed method was successfully applied to spiked human plasma samples and can be further useful for pharmacokinetic profiling. This approach employs a deuterated IS, which provides more accuracy and reduces matrix effects compared with existing LC‐MS and high‐performance LC methods. This method addresses the need for a sensitive and selective analysis of Solriamfetol, providing valuable insights into its pharmacological profile for the treatment of sleep‐related disorders.
11 27 2025 12 2025 e70169 10.1002/sscp.70169 2 10.1002/crossmark_policy analyticalsciencejournals.onlinelibrary.wiley.com true 2025-05-26 2025-11-13 2025-11-27 http://onlinelibrary.wiley.com/termsAndConditions#vor 10.1002/sscp.70169 https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/sscp.70169 https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/pdf/10.1002/sscp.70169 10.1056/NEJMra1500587 10.1016/j.ncl.2012.08.002 10.1016/j.sleep.2015.05.013 10.1177/1060028020915537 10.1378/chest.14‐0970 10.1007/s40263‐020‐00744‐2 10.5665/sleep.5968 10.1002/ana.25423 10.1164/rccm.201806‐1100OC 10.3389/fneur.2013.00139 10.1002/1098‐2396(20010101)39:1<32::AID‐SYN5>3.0.CO;2‐3 10.1124/jpet.118.248120 10.1016/j.sleep.2017.03.025 10.1007/s40263‐019‐00689‐1 10.1002/jcph.1402 10.22376/ijpbs/lpr.2021.11.3.L129‐138 10.1016/j.microc.2024.111930 10.1007/s11094‐023‐02991‐1 10.1016/j.jpha.2023.02.012 10.4103/0975‐7406.120068 Research Journal of Pharmacy and Technology Naga Prashant K. 5333 13 2020 A Validated Reverse Phase LC‐MS Method for Quantification of Drotaverine in Biological Matrices Drug Invention Today Prashant Koppuravuri N. 68 13 2020 Sensitive Liquid Chromatography‐Mass Spectrometry Method for the Quantification of Amifampridine in Plasma Using Liquid‐Liquid Extraction Technique 10.1002/sscp.202400162 10.1002/sscp.202400106 10.1002/sscp.70074 10.1155/2012/101249 Food and Drug Administration.Guidance for Industry: Bioanalytical Method Validation. (2001) http://www.fda.gov/cder/Guidance/4252fnl.pdf.